Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Abbott Laboratories
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Number of employees : 107 000 people.
Sales per Business
2019
USD (in Million)%
Medical Devices12,23938.4%
Diagnostics7,71324.2%
Nutritionals7,40923.2%
Established Pharmaceuticals4,48614.1%
Other57.000.2%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
All Other Countries11,21536.7%11,53436.2% +2.84%
United States10,83935.4%11,39835.7% +5.16%
China2,3117.6%2,3467.4% +1.51%
Germany1,6195.3%1,7515.5% +8.15%
Japan1,3264.3%1,4354.5% +8.22%
India1,3334.4%1,3974.4% +4.8%
Switzerland1,0053.3%1,0683.3% +6.27%
The Netherlands930.003%975.003.1% +4.84%
Managers
NameAgeSinceTitle
Robert Ford452020President, CEO, Chief Operating Officer & Director
Miles White642020Executive Chairman
Robert E. Funck572020Chief Financial Officer & Executive Vice President
Roxanne Austin582000Independent Director
Samuel C. Scott742007Independent Director
Glenn Fletcher Tilton702017Independent Director
William A. Osborn71-Lead Independent Director
Robert J. Alpern, Dr.682008Independent Director
Edward Michael Liddy732010Independent Director
Phebe Novakovic612010Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,979,594,379 1,758,150,887 88.8% 209,064,380 10.6% 88.8%
Shareholders
NameEquities%
The Vanguard Group, Inc. 141,677,968 8.00%
Capital Research & Management Co. 100,782,100 5.69%
Capital Research & Management Co. (Global Investors) 87,417,734 4.94%
SSgA Funds Management, Inc. 74,556,021 4.21%
Capital Research & Management Co. (International Investors) 56,714,070 3.20%
BlackRock Fund Advisors 42,612,898 2.41%
Wellington Management Co. LLP 35,926,910 2.03%
Northern Trust Investments, Inc.(Investment Management) 27,034,512 1.53%
Geode Capital Management LLC 25,238,694 1.43%
Massachusetts Financial Services Co. 24,455,855 1.38%
Holdings
NameEquities%Valuation
Abbott India Limited (500488) 15,934,04875.0%3,563,089,116 USD
Abbott Laboratories (Pakistan) Limited (ABOT) 76,259,45177.9%352,721,314 USD
Allergy Therapeutics plc (AGY) 240,584,57137.6%47,820,995 USD
Domesco Medical Import - Export Joint-Stock Corporation (DMC) 17,949,80051.7%46,457,852 USD
Kilroy Realty Corporation (KRC) 1650.0001%8,573 USD
Company contact information
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064-6400

Phone : +1.224.667.6100
Web : http://www.abbott.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Abbott Laboratories
Sector Medical Equipment, Supplies & Distribution - NEC